ProtoKinetix, Incorporated (PKTX)

Market Cap	82.33K -96.5%
Revenue (ttm)	n/a
Net Income	-393.65K
EPS	-0.00
Shares Out	411.63M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	230
Open	0.0002
Previous Close	n/a
Day's Range	0.0002 - 0.0002
52-Week Range	0.0001 - 0.0124
Beta	0.86
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications, such as targeted health care solutions, as well as AAGPs are used in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorpo...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: PKTX

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 26, 2026

Data Sources Report a data error